complex polygenic disease

Why is one person tall and another short? It is not one gene flipped like a light switch — it is the small push of hundreds of genes plus diet, sleep, and a dozen other things, all adding up. Most of the diseases that matter most to public health work the same way: heart disease, type 2 diabetes, common cancers, depression, asthma. These are complex, polygenic diseases — "polygenic" meaning many genes, "complex" meaning genes and environment tangled together.

Here is how it differs from a single-gene disease. In a single-gene disease, one gene's fault is enough to cause illness. In a polygenic disease, no single gene is enough; instead, hundreds or thousands of common DNA variants each nudge your risk up or down by a tiny amount, and only the combined load — together with environment and chance — tips a person over the line. Scientists hunt these variants with genome-wide association studies (GWAS), which scan the DNA of huge numbers of people to find variants that show up more often in those with the disease. Adding the small effects together gives a polygenic risk score, an estimate of inherited risk.

This is where most of the disease burden of modern societies sits, and it is also where the molecular story gets honestly messy. A polygenic risk score gives a probability, not a verdict: a high score means higher odds, not a diagnosis, and most carriers of "risk" variants never get the disease. Crucially, the variants a GWAS finds mark a region of the genome associated with risk — association is not causation, and the actual causal gene and mechanism often take years more to nail down. And because most large studies were done in people of European ancestry, today's risk scores work poorly for much of the world's population, a real equity problem.